Quality of Life Assessment Following Botulinum Toxin Injection in Patients with Adductor Spasmodic Dysphonia Using the 5-Factor Glasgow Benefit Inventory
Botulinum injection therapy for AdSD provides overall benefit to patients as measured by the GBI-5F, with particular improvement observed for perceived quality of life, self-confidence, and social involvement. Sex, presence/absence of vocal tremor, and age do not appear to modify benefit, though degree of functional improvement is positively correlated with total score.
Authors
- David G. Lott (ORCID: https://orcid.org/0000-0001-6541-9687)
- Michael A. Cirelli (ORCID: https://orcid.org/0009-0007-4561-8049)
- Charles H. Adler (ORCID: https://orcid.org/0000-0002-1045-2743)
- Michael J. Marino (ORCID: https://orcid.org/0000-0002-8672-0310)
- Stephen F. Bansberg (ORCID: https://orcid.org/0000-0002-2258-4495)
Institutions
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
Publication Details
- Journal
- Annals of Otology Rhinology & Laryngology
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1177/00034894251356728
- Primary Topic
- Voice and Speech Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00